Clinical Trial to Begin Using the NorDocs Technologies SmartStim™ tDCS
NorDocs Announces Collaboration with CAMH and OBI for Clinical Trial in Toronto
Ottawa, Ontario—September 14, 2012—NorDocs Technologies announced today that the Centre for Addiction and Mental Health (CAMH) has begun a clinical trial on smoking cessation using the SmartStim™ device developed by NorDocs. This clinical trial is being sponsored by the Ontario Brain Institute (OBI) to test the efficacy of transcranial direct current stimulation (tDCS) in the treatment of nicotine addiction. The year-long study is currently underway and is expected to be completed by September 2013.
“This study is a great example of the ongoing collaboration between industry and academic partners that will deliver better treatments and services for those afflicted with addiction and other brain disorders”, said Dr. Donald Stuss, President and Scientific Director at the Ontario Brain Institute.
The double-blind randomized controlled smoking cessation trial, led by Martin Zack, Ph.D, will take place at the Centre for Addiction and Mental Health in Toronto and will include 66 nicotine-dependent smokers (http://www.clinicaltrials.gov/ct2/show/NCT01710410). The study will include a trial of NorDocs’ SmartStim tDCS when combined with nicotine patch treatments. The participants will receive treatments over a 10-week period with the objective of the study to increase the duration of abstinence and to help prevent further relapse.
“We are excited about our collaboration with CAMH and OBI,” said Stanley Shapiro, MD, Co-Founder and CEO, NorDocs Technologies. “This collaborative study will help us to validate that tDCS is an effective treatment for nicotine addiction.”
About NorDocs: NorDocs Technologies was founded in 2010 by addiction medicine physicians with the purpose of finding a better way to address key challenges in the field of addiction. The company offers a complete suite of services to addiction clinics with the goal to improve treatment outcomes and reduce the long-term costs of care for addiction therapy. NorDocs is located in Sudbury, Ontario with R&D in Ottawa, Ontario, and is currently developing technologies for the assessment and treatment of addiction, beginning with nicotine and narcotic addictions.
To learn more about NorDocs Technologies please visit www.NorDocs.com
About CAMH: The Centre for Addiction and Mental Health is the leading mental health and addiction research facility in Canada, and one of the largest in the world.
About OBI: The Ontario Brain Institute aims to connect researchers in brain science from across the province.
VP Business Development, NorDocs Technologies
Inquiries by email: email@example.com
Inquiries by phone: 613-454-1228 ext 2